Henry O Gosebruch Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Henry O Gosebruch.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Henry O Gosebruch. Henry O Gosebruch is Chief Strategy Officer in AbbVie Inc. ($ABBV) and EVP, Chief Strategy Officer in AbbVie Inc. ($ABBV) and in Aptinyx Inc. ($APTX) and Director in Aptinyx Inc. ($APTX).
Latest Insider Trading Transactions of Henry O Gosebruch
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 107.74 | 22,833 | 2,460,027 | 48,711 | 71.5 K to 48.7 K (-31.91 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 105.92 | 49,068 | 5,197,283 | 49,068 | |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 14,724 | 0 | 71,544 | 56.8 K to 71.5 K (+25.91 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 7,972 | 0 | 56,820 | 48.8 K to 56.8 K (+16.32 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 6,555 | 0 | 48,848 | 42.3 K to 48.8 K (+15.50 %) |
| Feb 22 2021 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 22,287 | 0 | 42,293 | 20 K to 42.3 K (+111.40 %) |
| Nov 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Sell | S | 99.49 | 33,100 | 3,293,119 | 20,006 | 53.1 K to 20 K (-62.33 %) |
| Nov 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Sell | S | 98.83 | 6,900 | 681,927 | 53,106 | 60 K to 53.1 K (-11.50 %) |
| Oct 02 2020 | APTX | Aptinyx Inc. | Gosebruch Henry O | Option Exercise | A | 3.38 | 5,490 | 18,556 | 5,490 | ||
| May 22 2020 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Option Exercise | A | 3.84 | 40,000 | 153,600 | 40,000 | |
| Apr 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 18,500 | 0 | 48,500 | 30 K to 48.5 K (+61.67 %) |
| Apr 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 18,500 | 0 | 60,006 | 78.5 K to 60 K (-23.57 %) |
| Apr 02 2020 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Option Exercise | A | 2.16 | 7,374 | 15,928 | 7,374 | |
| Mar 03 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 85.42 | 26,038 | 2,224,166 | 78,506 | 104.5 K to 78.5 K (-24.91 %) |
| Mar 03 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 85.42 | 26,038 | 2,224,166 | 78,506 | 104.5 K to 78.5 K (-24.91 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 93.50 | 96,563 | 9,028,641 | 96,563 | |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 7,972 | 0 | 104,544 | 96.6 K to 104.5 K (+8.25 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 6,555 | 0 | 96,572 | 90 K to 96.6 K (+7.28 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 11,730 | 0 | 90,017 | 78.3 K to 90 K (+14.98 %) |
| Feb 24 2020 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 32,524 | 0 | 78,287 | 45.8 K to 78.3 K (+71.07 %) |
| Jan 14 2020 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Buy | P | 3.00 | 25,000 | 75,000 | 125,000 | 100 K to 125 K (+25.00 %) |
| Jan 03 2020 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Option Exercise | A | 3.42 | 4,668 | 15,965 | 4,668 | |
| Oct 07 2019 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Gift | G | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Oct 07 2019 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Gift | G | 0.00 | 100,000 | 0 | 0 | 100 K to 0 (-100.00 %) |
| Oct 02 2019 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Option Exercise | A | 3.49 | 4,419 | 15,422 | 4,419 | |
| Aug 16 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Aug 16 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Gift | G | 0.00 | 30,000 | 0 | 45,763 | 75.8 K to 45.8 K (-39.60 %) |
| Jul 31 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Buy | P | 67.28 | 30,000 | 2,018,385 | 75,763 | 45.8 K to 75.8 K (+65.56 %) |
| Jul 31 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Buy | P | 67.28 | 30,000 | 2,018,385 | 75,763 | 45.8 K to 75.8 K (+65.56 %) |
| May 17 2019 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Option Exercise | A | 3.73 | 80,000 | 298,400 | 80,000 | |
| May 09 2019 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Buy | P | 3.86 | 96,580 | 372,799 | 100,000 | 3.4 K to 100 K (+2,823.98 %) |
| May 09 2019 | APTX | Aptinyx Inc. | Gosebruch Henry O | Director | Buy | P | 3.75 | 3,420 | 12,825 | 3,420 | 0 to 3.4 K |
| Mar 04 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 79.41 | 22,956 | 1,822,936 | 45,763 | 68.7 K to 45.8 K (-33.41 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 79.02 | 49,065 | 3,877,116 | 49,065 | |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 6,555 | 0 | 68,719 | 62.2 K to 68.7 K (+10.54 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 11,730 | 0 | 62,164 | 50.4 K to 62.2 K (+23.26 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 14,035 | 0 | 50,434 | 36.4 K to 50.4 K (+38.56 %) |
| Feb 22 2019 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 19,495 | 0 | 36,399 | 16.9 K to 36.4 K (+115.33 %) |
| Dec 11 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 86.96 | 13,446 | 1,169,264 | 16,904 | 30.4 K to 16.9 K (-44.30 %) |
| Nov 30 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Sell | S | 90.10 | 42,450 | 3,824,940 | 30,350 | 72.8 K to 30.4 K (-58.31 %) |
| Mar 02 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Payment of Exercise | F | 118.26 | 17,418 | 2,059,853 | 72,800 | 90.2 K to 72.8 K (-19.31 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Option Exercise | A | 114.36 | 35,440 | 4,052,918 | 35,440 | |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 11,730 | 0 | 90,218 | 78.5 K to 90.2 K (+14.94 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 13,552 | 0 | 78,488 | 64.9 K to 78.5 K (+20.87 %) |
| Feb 16 2018 | ABBV | AbbVie Inc. | Gosebruch Henry O | EVP, Chief Strategy ... | Grant | A | 0.00 | 14,034 | 0 | 64,936 | 50.9 K to 64.9 K (+27.57 %) |
| Dec 11 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Payment of Exercise | F | 95.95 | 14,235 | 1,365,848 | 50,902 | 65.1 K to 50.9 K (-21.85 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 92.02 | 100 | 9,202 | 65,137 | 65.2 K to 65.1 K (-0.15 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 91.22 | 4,482 | 408,849 | 65,237 | 69.7 K to 65.2 K (-6.43 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 90.49 | 11,568 | 1,046,814 | 69,719 | 81.3 K to 69.7 K (-14.23 %) |
| Oct 31 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 89.38 | 2,150 | 192,172 | 81,287 | 83.4 K to 81.3 K (-2.58 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.45 | 200 | 14,090 | 83,437 | 83.6 K to 83.4 K (-0.24 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.37 | 100 | 7,037 | 83,637 | 83.7 K to 83.6 K (-0.12 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.34 | 100 | 7,034 | 83,737 | 83.8 K to 83.7 K (-0.12 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.29 | 100 | 7,029 | 83,837 | 83.9 K to 83.8 K (-0.12 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.25 | 200 | 14,050 | 83,937 | 84.1 K to 83.9 K (-0.24 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.23 | 600 | 42,138 | 84,137 | 84.7 K to 84.1 K (-0.71 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.22 | 400 | 28,088 | 84,737 | 85.1 K to 84.7 K (-0.47 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.21 | 700 | 49,147 | 85,137 | 85.8 K to 85.1 K (-0.82 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.20 | 500 | 35,100 | 85,837 | 86.3 K to 85.8 K (-0.58 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.19 | 1,200 | 84,228 | 86,337 | 87.5 K to 86.3 K (-1.37 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.19 | 300 | 21,056 | 87,537 | 87.8 K to 87.5 K (-0.34 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.18 | 500 | 35,090 | 87,837 | 88.3 K to 87.8 K (-0.57 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.18 | 200 | 14,035 | 88,337 | 88.5 K to 88.3 K (-0.23 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.17 | 400 | 28,068 | 88,537 | 88.9 K to 88.5 K (-0.45 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.16 | 600 | 42,096 | 88,937 | 89.5 K to 88.9 K (-0.67 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.15 | 100 | 7,015 | 89,537 | 89.6 K to 89.5 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.14 | 100 | 7,014 | 89,637 | 89.7 K to 89.6 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.13 | 800 | 56,104 | 89,737 | 90.5 K to 89.7 K (-0.88 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.12 | 700 | 49,084 | 90,537 | 91.2 K to 90.5 K (-0.77 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.12 | 200 | 14,023 | 91,237 | 91.4 K to 91.2 K (-0.22 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.11 | 1,000 | 70,110 | 91,437 | 92.4 K to 91.4 K (-1.08 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.10 | 400 | 28,040 | 92,437 | 92.8 K to 92.4 K (-0.43 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.09 | 100 | 7,009 | 92,837 | 92.9 K to 92.8 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.08 | 100 | 7,008 | 92,937 | 93 K to 92.9 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.07 | 400 | 28,028 | 93,037 | 93.4 K to 93 K (-0.43 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.05 | 100 | 7,005 | 93,437 | 93.5 K to 93.4 K (-0.11 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.04 | 300 | 21,012 | 93,537 | 93.8 K to 93.5 K (-0.32 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.02 | 600 | 42,012 | 93,837 | 94.4 K to 93.8 K (-0.64 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.01 | 1,537 | 107,605 | 94,437 | 96 K to 94.4 K (-1.60 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.01 | 100 | 7,001 | 95,974 | 96.1 K to 96 K (-0.10 %) |
| Aug 02 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Sell | S | 70.00 | 5,663 | 396,410 | 96,074 | 101.7 K to 96.1 K (-5.57 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Option Exercise | A | 61.36 | 78,340 | 4,806,942 | 78,340 | |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 14,035 | 0 | 122,410 | 108.4 K to 122.4 K (+12.95 %) |
| Feb 21 2017 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 31,196 | 0 | 108,375 | 77.2 K to 108.4 K (+40.42 %) |
| Dec 09 2016 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Payment of Exercise | F | 60.90 | 13,871 | 844,744 | 77,179 | 91.1 K to 77.2 K (-15.23 %) |
| Feb 22 2016 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Option Exercise | A | 54.86 | 83,960 | 4,606,046 | 83,960 | |
| Dec 11 2015 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 64,540 | 0 | 91,050 | 26.5 K to 91.1 K (+243.46 %) |
| Dec 11 2015 | ABBV | AbbVie Inc. | Gosebruch Henry O | Chief Strategy Offi ... | Grant | A | 0.00 | 26,510 | 0 | 26,510 | 0 to 26.5 K |
Page: 1